相关实验视频

Updated: Sep 18, 2025

A 3D Organotypic Melanoma Spheroid Skin Model

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

阿托皮改善了生存率,并降低了皮肤黑色素瘤中大脑转移的风险

Corey Neff¹, Mackenzie Price¹, Christine Ann Pittman Ballard¹

¹Department of Neurosurgery, Duke University School of Medicine, Durham, North Carolina.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

|June 23, 2025

概括

患有亚托皮 (过敏性疾病) 病史的个人经历了改善的生存率和减少黑色素瘤大脑转移 (BrM) 的发生率. 这表明阿托皮可能表明对癌症治疗有更强的免疫反应.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
流行病学流行病学

背景情况:

黑色素瘤疗法增加了生存率,导致更多患者发展大脑转移 (BrM).
识别 BrM 风险较高的个体对于公共卫生至关重要.
(过敏性疾病) 是常见的,可能会影响癌症的结果.

研究的目的:

为了研究在黑色素瘤患者的亚托皮史和生存之间的关联.
评估亚托皮对黑色素瘤中BrM累积发病率 (CI) 的影响.
确定阿托皮是否是黑色素瘤治疗反应和免疫功能的预测标记.

主要方法:

使用链接的监测,流行病学和最终结果 (SEER) 和医疗保险数据的回顾性研究.
纳入标准:66岁或以上的皮肤黑色素瘤患者.
通过ICD-9/10代码确定亚托皮病史;使用Cox比例危险模型分析生存率和BrM CI.

主要成果:

总共有23,508例黑色素瘤病例被分析;6.1%的病例发展为BrM,38%的病例有亚托皮病史.
亚托皮与18%的死亡率降低显著相关 (P < 0.001).
在诊断时没有转移的患者中,Atopy降低了16%的BrM CI (P = 0.006). 使用检查点抑制剂的存活率在转移的亚托皮患者中明显更好.

结论:

亚托皮病史与改善整体存活率和降低老年黑色素瘤患者的BrM发病率有关.
亚托皮可以作为一个生物标志物,用于具有更强大的免疫功能的黑色素瘤患者的一个子集.
这个小组可能会对癌症疗法有更强的反应.

更多相关视频

Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma

Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma

Published on: September 8, 2021

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis

Published on: February 8, 2017

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Skin Cancer

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...